CDAK Annual CFO
-$74.14 M
-$10.78 M-17.02%
31 December 2021
Summary:
As of February 5, 2025, CDAK annual cash flow from operations is -$74.14 million, with the most recent change of -$10.78 million (-17.02%) on December 31, 2021. During the last 3 years, it has fallen by -$43.57 million (-142.51%).CDAK Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDAK Quarterly CFO
-$10.11 M
+$4.49 M+30.74%
30 September 2022
Summary:
As of February 5, 2025, CDAK quarterly cash flow from operations is -$10.11 million, with the most recent change of +$4.49 million (+30.74%) on September 30, 2022. Over the past year, it has increased by +$5.19 million (+33.93%).CDAK Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDAK TTM CFO
-$67.08 M
+$5.19 M+7.18%
30 September 2022
Summary:
As of February 5, 2025, CDAK TTM cash flow from operations is -$67.08 million, with the most recent change of +$5.19 million (+7.18%) on September 30, 2022. Over the past year, it has increased by +$19.41 million (+22.44%).CDAK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDAK Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.0% | +33.9% | +22.4% |
| 3 y3 years | -142.5% | - | - |
| 5 y5 years | -142.5% | - | - |
CDAK Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +4253.7% | -322.7% | +364.2% |
Codiak BioSciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$10.11 M(-30.7%) | -$67.08 M(-7.2%) |
| June 2022 | - | -$14.60 M(-30.0%) | -$72.27 M(-4.1%) |
| Mar 2022 | - | -$20.85 M(-3.1%) | -$75.36 M(+1.6%) |
| Dec 2021 | -$74.14 M | -$21.52 M(+40.6%) | -$74.14 M(-14.3%) |
| Sept 2021 | - | -$15.30 M(-13.5%) | -$86.49 M(+0.3%) |
| June 2021 | - | -$17.68 M(-10.0%) | -$86.23 M(+34.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$19.64 M(-42.0%) | -$64.01 M(+1.0%) |
| Dec 2020 | -$63.36 M(+3620.6%) | -$33.87 M(+125.2%) | -$63.36 M(+114.8%) |
| Sept 2020 | - | -$15.04 M(-431.4%) | -$29.49 M(+104.1%) |
| June 2020 | - | $4.54 M(-123.9%) | -$14.45 M(-23.9%) |
| Mar 2020 | - | -$18.99 M | -$18.99 M |
| Dec 2019 | -$1.70 M(-94.4%) | - | - |
| Dec 2018 | -$30.57 M | - | - |
FAQ
- What is Codiak BioSciences annual cash flow from operations?
- What is the all time high annual CFO for Codiak BioSciences?
- What is Codiak BioSciences annual CFO year-on-year change?
- What is Codiak BioSciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Codiak BioSciences?
- What is Codiak BioSciences quarterly CFO year-on-year change?
- What is Codiak BioSciences TTM cash flow from operations?
- What is the all time high TTM CFO for Codiak BioSciences?
- What is Codiak BioSciences TTM CFO year-on-year change?
What is Codiak BioSciences annual cash flow from operations?
The current annual CFO of CDAK is -$74.14 M
What is the all time high annual CFO for Codiak BioSciences?
Codiak BioSciences all-time high annual cash flow from operations is -$1.70 M
What is Codiak BioSciences annual CFO year-on-year change?
Over the past year, CDAK annual cash flow from operations has changed by -$10.78 M (-17.02%)
What is Codiak BioSciences quarterly cash flow from operations?
The current quarterly CFO of CDAK is -$10.11 M
What is the all time high quarterly CFO for Codiak BioSciences?
Codiak BioSciences all-time high quarterly cash flow from operations is $4.54 M
What is Codiak BioSciences quarterly CFO year-on-year change?
Over the past year, CDAK quarterly cash flow from operations has changed by +$5.19 M (+33.93%)
What is Codiak BioSciences TTM cash flow from operations?
The current TTM CFO of CDAK is -$67.08 M
What is the all time high TTM CFO for Codiak BioSciences?
Codiak BioSciences all-time high TTM cash flow from operations is -$14.45 M
What is Codiak BioSciences TTM CFO year-on-year change?
Over the past year, CDAK TTM cash flow from operations has changed by +$19.41 M (+22.44%)